$MRNA·8-K

Moderna, Inc. · May 1, 6:32 AM ET

Compare

Moderna, Inc. 8-K

Research Summary

AI-generated summary

Updated

Moderna, Inc. Reports Q1 2026 Financial Results

What Happened
Moderna, Inc. announced its financial results for the quarter ended March 31, 2026 via a press release dated May 1, 2026. The company filed a Form 8-K (Item 2.02) to furnish that press release and attached it as Exhibit 99.1. The Form 8-K states the release is "furnished" — not "filed" — for purposes of Section 18 of the Securities Exchange Act. The report was signed by James M. Mock, Chief Financial Officer, on May 1, 2026.

Key Details

  • Press release announcing Q1 2026 results dated May 1, 2026 and furnished as Exhibit 99.1.
  • Reporting period: quarter ended March 31, 2026.
  • Information in the 8-K and Exhibit 99.1 is furnished (not filed) and thus not subject to Section 18 liability or automatically incorporated by reference into other filings.
  • Form 8-K was signed by James M. Mock, CFO, on May 1, 2026.

Why It Matters
This 8-K signals Moderna's official public release of quarterly earnings and related financial information — material data investors use to assess revenue, profitability and near-term outlook. Because the press release is furnished rather than filed, investors should review the attached Exhibit 99.1 and Moderna’s subsequent periodic filings (e.g., the 10-Q) for complete, audited financial statements and any forward-looking guidance.

Loading document...